Home BIOTECH Stocks To Eyes On: Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), Star Scientific, Inc.(NASDAQ:STSI), InterOil Corporation (USA) (NYSE:IOC)

Stocks To Eyes On: Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), Star Scientific, Inc.(NASDAQ:STSI), InterOil Corporation (USA) (NYSE:IOC)

0
0

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) shares gained 7.41% to $0.580. The company on July 24 announced that it has received commitments from a single healthcare dedicated institutional investor to purchase an aggregate of approximately $5.7 million of the Company’s common stock.

The Company entered into definitive purchase agreement with this investor pursuant to which the Company agreed to sell an aggregate of 11,400,000 shares of its common stock and warrants exercisable for up to approximately 3,990,000 additional shares of its common stock.

Star Scientific, Inc.(NASDAQ:STSI) shares jumped 7.37% to $2.04 on no official news. The company on May 10 reported net sales of $2.5 million for the quarter ended March 31, 2013, compared with $1.1 million for the same period in 2012. The net loss for first-quarter 2013 was $(8.2) million compared with a $(5.2) million net loss for the same period in 2012.

During the first quarter of 2013, the company expanded the Anatabloc® cosmetic products line with the introduction of Anatabloc® Revitalizing Facial Serum.

InterOil Corporation (USA) (NYSE:IOC) shares jumped 6.82% to $88.47. The company announces that it will release financial and operating results for the second quarter of 2013 after the market closes for trading on Monday, August 12, 2013. A conference call will be held on Tuesday, August 13, 2013, at 7:30 a.m. Central (8:30 a.m. Eastern) to discuss the financial and operating results, as well as the company’s outlook.

Additionally, the company on July 17 announced that IOC and its subsidiaries, EP InterOil and InterOil Limited, have entered into a $350.0 million working capital structured facility arranged by BNP Paribas (BNP), also acting as lead manager, to replace the existing $240.0 million bilateral working capital facility with BNP.